Effects of type 2 diabetes on brain structure and cognitive function: African American-diabetes heart study MIND

C. T. Whitlow, K. M. Sink, J. Divers, S. C. Smith, J. Xu, N. D. Palmer, C. E. Hugenschmidt, J. D. Williamson, D. W. Bowden, B. I. Freedman, Joseph A Maldjian

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Rates of type 2 diabetes are higher among African Americans compared with individuals of European ancestry. The purpose of this investigation was to determine the relationship between MR imaging measures of brain structure (volume of GM, WM, WM lesions) and cognitive function in a population of African Americans with type 2 diabetes. These MR imaging measures of brain structure are affected by type 2 diabetes-associated macrovascular and microvascular disease and may be associated with performance on tasks of cognitive function in the understudied African American population. MATERIALSANDMETHODS: African Americans with type 2 diabetes enrolled in the African American-Diabetes Heart StudyMINDstudy (n=263) were evaluated across a broad range of cognitive domains and imaged with brain MR imaging. Associations between cognitive parameters and MR imaging measures of whole-brain GM, WM, andWMlesion volumes were assessed by using adjusted multivariate models. RESULTS: Lower GM volume was associated with poorer performance on measures of general cognitive function, working memory, and executive function. Higher WM lesion volume was associated with poorer performance on a smaller subset of cognitive domains compared with GM volume but included aspects of working memory and executive function. There were no statistically significant associations with WM volume. CONCLUSIONS: Markers of cortical atrophy and WM lesion volume are associated with cognitive function in African Americans with type 2 diabetes. These associations are described in an African American cohort with disease control similar to that of individuals of European ancestry, rather than underserved African Americans with poor access to health care. Interventions to reduce cortical atrophy and WM disease may improve cognitive outcomes in this understudied population.

Original languageEnglish (US)
Pages (from-to)1648-1653
Number of pages6
JournalAmerican Journal of Neuroradiology
Volume36
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

African Americans
Type 2 Diabetes Mellitus
Cognition
Brain
Neuroimaging
Executive Function
Short-Term Memory
Atrophy
Population
Health Services Accessibility
Task Performance and Analysis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

Effects of type 2 diabetes on brain structure and cognitive function : African American-diabetes heart study MIND. / Whitlow, C. T.; Sink, K. M.; Divers, J.; Smith, S. C.; Xu, J.; Palmer, N. D.; Hugenschmidt, C. E.; Williamson, J. D.; Bowden, D. W.; Freedman, B. I.; Maldjian, Joseph A.

In: American Journal of Neuroradiology, Vol. 36, No. 9, 01.09.2015, p. 1648-1653.

Research output: Contribution to journalArticle

Whitlow, CT, Sink, KM, Divers, J, Smith, SC, Xu, J, Palmer, ND, Hugenschmidt, CE, Williamson, JD, Bowden, DW, Freedman, BI & Maldjian, JA 2015, 'Effects of type 2 diabetes on brain structure and cognitive function: African American-diabetes heart study MIND', American Journal of Neuroradiology, vol. 36, no. 9, pp. 1648-1653. https://doi.org/10.3174/ajnr.A4321
Whitlow, C. T. ; Sink, K. M. ; Divers, J. ; Smith, S. C. ; Xu, J. ; Palmer, N. D. ; Hugenschmidt, C. E. ; Williamson, J. D. ; Bowden, D. W. ; Freedman, B. I. ; Maldjian, Joseph A. / Effects of type 2 diabetes on brain structure and cognitive function : African American-diabetes heart study MIND. In: American Journal of Neuroradiology. 2015 ; Vol. 36, No. 9. pp. 1648-1653.
@article{bbacaeae91534c84984fb536e426d7f7,
title = "Effects of type 2 diabetes on brain structure and cognitive function: African American-diabetes heart study MIND",
abstract = "BACKGROUND AND PURPOSE: Rates of type 2 diabetes are higher among African Americans compared with individuals of European ancestry. The purpose of this investigation was to determine the relationship between MR imaging measures of brain structure (volume of GM, WM, WM lesions) and cognitive function in a population of African Americans with type 2 diabetes. These MR imaging measures of brain structure are affected by type 2 diabetes-associated macrovascular and microvascular disease and may be associated with performance on tasks of cognitive function in the understudied African American population. MATERIALSANDMETHODS: African Americans with type 2 diabetes enrolled in the African American-Diabetes Heart StudyMINDstudy (n=263) were evaluated across a broad range of cognitive domains and imaged with brain MR imaging. Associations between cognitive parameters and MR imaging measures of whole-brain GM, WM, andWMlesion volumes were assessed by using adjusted multivariate models. RESULTS: Lower GM volume was associated with poorer performance on measures of general cognitive function, working memory, and executive function. Higher WM lesion volume was associated with poorer performance on a smaller subset of cognitive domains compared with GM volume but included aspects of working memory and executive function. There were no statistically significant associations with WM volume. CONCLUSIONS: Markers of cortical atrophy and WM lesion volume are associated with cognitive function in African Americans with type 2 diabetes. These associations are described in an African American cohort with disease control similar to that of individuals of European ancestry, rather than underserved African Americans with poor access to health care. Interventions to reduce cortical atrophy and WM disease may improve cognitive outcomes in this understudied population.",
author = "Whitlow, {C. T.} and Sink, {K. M.} and J. Divers and Smith, {S. C.} and J. Xu and Palmer, {N. D.} and Hugenschmidt, {C. E.} and Williamson, {J. D.} and Bowden, {D. W.} and Freedman, {B. I.} and Maldjian, {Joseph A}",
year = "2015",
month = "9",
day = "1",
doi = "10.3174/ajnr.A4321",
language = "English (US)",
volume = "36",
pages = "1648--1653",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "9",

}

TY - JOUR

T1 - Effects of type 2 diabetes on brain structure and cognitive function

T2 - African American-diabetes heart study MIND

AU - Whitlow, C. T.

AU - Sink, K. M.

AU - Divers, J.

AU - Smith, S. C.

AU - Xu, J.

AU - Palmer, N. D.

AU - Hugenschmidt, C. E.

AU - Williamson, J. D.

AU - Bowden, D. W.

AU - Freedman, B. I.

AU - Maldjian, Joseph A

PY - 2015/9/1

Y1 - 2015/9/1

N2 - BACKGROUND AND PURPOSE: Rates of type 2 diabetes are higher among African Americans compared with individuals of European ancestry. The purpose of this investigation was to determine the relationship between MR imaging measures of brain structure (volume of GM, WM, WM lesions) and cognitive function in a population of African Americans with type 2 diabetes. These MR imaging measures of brain structure are affected by type 2 diabetes-associated macrovascular and microvascular disease and may be associated with performance on tasks of cognitive function in the understudied African American population. MATERIALSANDMETHODS: African Americans with type 2 diabetes enrolled in the African American-Diabetes Heart StudyMINDstudy (n=263) were evaluated across a broad range of cognitive domains and imaged with brain MR imaging. Associations between cognitive parameters and MR imaging measures of whole-brain GM, WM, andWMlesion volumes were assessed by using adjusted multivariate models. RESULTS: Lower GM volume was associated with poorer performance on measures of general cognitive function, working memory, and executive function. Higher WM lesion volume was associated with poorer performance on a smaller subset of cognitive domains compared with GM volume but included aspects of working memory and executive function. There were no statistically significant associations with WM volume. CONCLUSIONS: Markers of cortical atrophy and WM lesion volume are associated with cognitive function in African Americans with type 2 diabetes. These associations are described in an African American cohort with disease control similar to that of individuals of European ancestry, rather than underserved African Americans with poor access to health care. Interventions to reduce cortical atrophy and WM disease may improve cognitive outcomes in this understudied population.

AB - BACKGROUND AND PURPOSE: Rates of type 2 diabetes are higher among African Americans compared with individuals of European ancestry. The purpose of this investigation was to determine the relationship between MR imaging measures of brain structure (volume of GM, WM, WM lesions) and cognitive function in a population of African Americans with type 2 diabetes. These MR imaging measures of brain structure are affected by type 2 diabetes-associated macrovascular and microvascular disease and may be associated with performance on tasks of cognitive function in the understudied African American population. MATERIALSANDMETHODS: African Americans with type 2 diabetes enrolled in the African American-Diabetes Heart StudyMINDstudy (n=263) were evaluated across a broad range of cognitive domains and imaged with brain MR imaging. Associations between cognitive parameters and MR imaging measures of whole-brain GM, WM, andWMlesion volumes were assessed by using adjusted multivariate models. RESULTS: Lower GM volume was associated with poorer performance on measures of general cognitive function, working memory, and executive function. Higher WM lesion volume was associated with poorer performance on a smaller subset of cognitive domains compared with GM volume but included aspects of working memory and executive function. There were no statistically significant associations with WM volume. CONCLUSIONS: Markers of cortical atrophy and WM lesion volume are associated with cognitive function in African Americans with type 2 diabetes. These associations are described in an African American cohort with disease control similar to that of individuals of European ancestry, rather than underserved African Americans with poor access to health care. Interventions to reduce cortical atrophy and WM disease may improve cognitive outcomes in this understudied population.

UR - http://www.scopus.com/inward/record.url?scp=84941354939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941354939&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A4321

DO - 10.3174/ajnr.A4321

M3 - Article

C2 - 26206811

AN - SCOPUS:84941354939

VL - 36

SP - 1648

EP - 1653

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 9

ER -